| Norditropin |
021148 |
006 |
351(a) |
somatropin |
Injection |
Subcutaneous |
15MG/1.5ML |
Autoinjector |
2004/10/01
|
Novo Nordisk Inc. |
Disc |
Licensed |
N/A |
N/A |
| Enbrel |
103795 |
003 |
351(a) |
etanercept |
Injection |
Subcutaneous |
50MG/ML |
Pre-Filled Syringe |
2004/09/27
|
Immunex Corporation |
Rx |
Licensed |
N/A |
N/A |
| Synagis |
103770 |
003 |
351(a) |
palivizumab |
Injection |
Intramuscular |
50MG/0.5ML |
Single-Dose Vial |
2004/07/23
|
Swedish Orphan Biovitrum AB (publ) |
Rx |
Licensed |
N/A |
N/A |
| Synagis |
103770 |
004 |
351(a) |
palivizumab |
Injection |
Intramuscular |
100MG/1ML |
Single-Dose Vial |
2004/07/23
|
Swedish Orphan Biovitrum AB (publ) |
Rx |
Licensed |
N/A |
N/A |
| NeutroSpec |
103928 |
001 |
351(a) |
technetium 99m tc fanolesomab |
Injection |
Intravenous |
0.25MG |
Single-Dose Vial |
2004/07/02
|
Palatin Technologies, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Jeanatope |
017836 |
003 |
351(a) |
iodinated I-125 albumin |
Injection |
Intravenous |
100uCi/10ML (10uCi/ML) |
Multi-Dose Vial |
2004/06/08
|
Iso-Tex Diagnostics, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegasys Copegus Combination Pack |
125083 |
001 |
351(a) |
peginterferon alfa-2a and ribavirin |
|
|
180MCG/0.5ML & 800MG |
|
2004/06/04
|
Hoffmann-La Roche Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegasys Copegus Combination Pack |
125083 |
002 |
351(a) |
peginterferon alfa-2a and ribavirin |
|
|
180MCG/0.5ML &1000MG |
|
2004/06/04
|
Hoffmann-La Roche Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegasys Copegus Combination Pack |
125083 |
003 |
351(a) |
peginterferon alfa-2a and ribavirin |
|
|
180MCG/0.5ML & 1200MG |
|
2004/06/04
|
Hoffmann-La Roche Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Gonal-f RFF RediJect |
021684 |
001 |
351(a) |
follitropin alfa |
Injection |
Subcutaneous |
300IU/0.5ML |
Autoinjector |
2004/05/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f RFF RediJect |
021684 |
002 |
351(a) |
follitropin alfa |
Injection |
Subcutaneous |
450IU/0.75ML |
Autoinjector |
2004/05/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f RFF RediJect |
021684 |
003 |
351(a) |
follitropin alfa |
Injection |
Subcutaneous |
900IU/1.5ML |
Autoinjector |
2004/05/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Octagam |
125062 |
001 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 5.0G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
002 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 1.0G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
003 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 10G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
004 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 2.5G |
Single-Use Bottle |
2004/05/21
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Vitrase |
021640 |
001 |
351(a) |
hyaluronidase |
Injection |
Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous |
6,200UNITS/ML |
Single-Dose Vial |
2004/05/05
|
Bausch & Lomb Incorporated |
Disc |
Licensed |
N/A |
N/A |
| Novolog |
020986 |
004 |
351(a) |
insulin aspart |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2004/04/23
|
Novo Nordisk Inc. |
Disc |
Licensed |
N/A |
N/A |
| Apidra |
021629 |
001 |
351(a) |
insulin glulisine |
Injection |
Intravenous, Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
2004/04/16
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f |
020378 |
005 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
450IU (600IU/ML) |
Multi-Dose Vial |
2004/03/26
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |